Gully D - Search Results

1

Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity.

Rowe WB, Nicot A, Sharma S, Gully D, Walker CD, Rostène WH, Meaney MJ, Quirion R. Rowe WB, et al. Among authors: gully d. Neuroendocrinology. 1997 Aug;66(2):75-85. doi: 10.1159/000127223. Neuroendocrinology. 1997. PMID: 9263204

2

Blockade of neurotensin binding in the rat hypothalamus and of the central action of neurotensin on the hypothalamic-pituitary-adrenal axis with non-peptide receptor antagonists.

Nicot A, Bérod A, Gully D, Rowe W, Quirion R, de Kloet ER, Rostène W. Nicot A, et al. Among authors: gully d. Neuroendocrinology. 1994 Jun;59(6):572-8. doi: 10.1159/000126707. Neuroendocrinology. 1994. PMID: 8084381

3

Increase in neurotensin receptor expression in rat brain induced by chronic treatment with the nonpeptide neurotensin receptor antagonist SR 48692.

Azzi M, Nicot A, Gully D, Kitabgi P, Bérod A, Rostène W. Azzi M, et al. Among authors: gully d. Neurosci Lett. 1994 May 19;172(1-2):97-100. doi: 10.1016/0304-3940(94)90671-8. Neurosci Lett. 1994. PMID: 8084546

4

Effect of the neurotensin receptor antagonist SR48692 on rat blood pressure modulation by neurotensin.

Gully D, Lespy L, Canton M, Rostène W, Kitabgi P, Le Fur G, Maffrand JP. Gully D, et al. Life Sci. 1996;58(8):665-74. doi: 10.1016/s0024-3205(96)80005-1. Life Sci. 1996. PMID: 8594316

5

[Neurotensin receptor antagonists and therapeutical perspectives].

Gully D, Maffrand JP, Soubrié P, Rostène W, Kitabgi P, Le Fur G. Gully D, et al. Therapie. 1995 Jan-Feb;50(1):5-7. Therapie. 1995. PMID: 7754478 Review. French.

6

Characterization and distribution of binding sites for a new neurotensin receptor antagonist ligand, [3H]SR 48692, in the guinea pig brain.

Betancur C, Canton M, Gully D, Vela G, Pélaprat D, Rostène W. Betancur C, et al. Among authors: gully d. J Pharmacol Exp Ther. 1995 Jun;273(3):1450-8. J Pharmacol Exp Ther. 1995. PMID: 7791120 Free PMC article.

7

Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems.

Rostène W, Sarrieau A, Nicot A, Scarceriaux V, Betancur C, Gully D, Meaney M, Rowe W, De Kloet R, Pelaprat D, et al. Rostène W, et al. Among authors: gully d. J Psychiatry Neurosci. 1995 Nov;20(5):349-56. J Psychiatry Neurosci. 1995. PMID: 8527421 Free PMC article.

8

Neurotensin receptor interaction with dopaminergic systems in the guinea-pig brain shown by neurotensin receptor antagonists.

Azzi M, Gully D, Heaulme M, Bérod A, Pélaprat D, Kitabgi P, Boigegrain R, Maffrand JP, LeFur G, Rostène W. Azzi M, et al. Among authors: gully d. Eur J Pharmacol. 1994 Apr 1;255(1-3):167-74. doi: 10.1016/0014-2999(94)90095-7. Eur J Pharmacol. 1994. PMID: 8026542

9

SR 48692 inhibits neurotensin-induced [3H]dopamine release in rat striatal slices and mesencephalic cultures.

Brouard A, Heaulme M, Leyris R, Pelaprat D, Gully D, Kitabgi P, Le Fur G, Rostene W. Brouard A, et al. Among authors: gully d. Eur J Pharmacol. 1994 Mar 3;253(3):289-91. doi: 10.1016/0014-2999(94)90204-6. Eur J Pharmacol. 1994. PMID: 8200423

10

Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.

Betancur C, Canton M, Burgos A, Labeeuw B, Gully D, Rostène W, Pélaprat D. Betancur C, et al. Among authors: gully d. Eur J Pharmacol. 1998 Feb 5;343(1):67-77. doi: 10.1016/s0014-2999(97)01510-0. Eur J Pharmacol. 1998. PMID: 9551716

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

100 results

Search Page

Filters